THORN RUN PARTNERS

Lobbying for AMYLYX · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Advocating for the education and advancement of cures for ALS, as well as working to meet the needs of ALS patients.

Budget/Appropriations

Labor-H Appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.